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Abstract
Background: The development of insulin resistance (IR) in mouse models of obesity and type 2 diabetes mellitus (DM) is
characterized by progressive accumulation of inflammatory macrophages and subpopulations of T cells in the visceral
adipose. Regulatory T cells (Tregs) may play a critical role in modulating tissue inflammation via their interactions with both
adaptive and innate immune mechanisms. We hypothesized that an imbalance in Tregs is a critical determinant of adipose
inflammation and investigated the role of Tregs in IR/obesity through coordinated studies in mice and humans.
Methods and Findings: Foxp3-green fluorescent protein (GFP) ‘‘knock-in’’ mice were randomized to a high-fat diet
intervention for a duration of 12 weeks to induce DIO/IR. Morbidly obese humans without overt type 2 DM (n=13) and lean
controls (n=7) were recruited prospectively for assessment of visceral adipose inflammation. DIO resulted in increased
CD3
+CD4
+, and CD3
+CD8
+ cells in visceral adipose with a striking decrease in visceral adipose Tregs. Treg numbers in
visceral adipose inversely correlated with CD11b
+CD11c
+ adipose tissue macrophages (ATMs). Splenic Treg numbers were
increased with up-regulation of homing receptors CXCR3 and CCR7 and marker of activation CD44. In-vitro differentiation
assays showed an inhibition of Treg differentiation in response to conditioned media from inflammatory macrophages.
Human visceral adipose in morbid obesity was characterized by an increase in CD11c
+ ATMs and a decrease in foxp3
expression.
Conclusions: Our experiments indicate that obesity in mice and humans results in adipose Treg depletion. These changes
appear to occur via reduced local differentiation rather than impaired homing. Our findings implicate a role for Tregs as
determinants of adipose inflammation.
Citation: Deiuliis J, Shah Z, Shah N, Needleman B, Mikami D, et al. (2011) Visceral Adipose Inflammation in Obesity Is Associated with Critical Alterations in
Tregulatory Cell Numbers. PLoS ONE 6(1): e16376. doi:10.1371/journal.pone.0016376
Editor: Vladimir Brusic, Dana-Farber Cancer Institute, United States of America
Received October 6, 2010; Accepted December 13, 2010; Published January 26, 2011
Copyright:  2011 Deiuliis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The project described was supported by Award Number F32DK083903 from the National Institute of Diabetes And Digestive And Kidney Diseases
awarded to Dr. Deiuliis. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of
Diabetes And Digestive And Kidney Diseases or the National Institutes of Health. Dr. Rajagopalan is supported by an R01 award from the NIEHS ‘‘Air Pollution and
Vascular Mechanisms’’ (ES015146) and R21 award NIDDK ‘‘T Regulatory Cells as Determinants of Inflammation in Adipose Tissue’’ (DK088522) grants. Dr. Sun is
supported by an NIEHS KO1 award "Air Pollution and Microvascular Dysfunction: Leukocyte Dependent NAD(P)H Oxidase" (ES016588). The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: deiuliis.1@osu.edu
Introduction
Visceral adipose inflammation is believed to play an etiologic role
inthedevelopmentofinsulinresistance (IR)inobesityand istypified
by early, and often dramatic, increases in innate immune cells such
as macrophages. Recently, multiple groups have demonstrated an
increase in visceral adipose T lymphocyte subsets (ATL) in mouse
and human obesity [1,2,3,4]. The relationship between alterations
in innate and adaptive immune cell numbers and function in the
adipose and their contribution to the eventual development of
obesity and related IR remains unclear. It has been suggested that
sub-sets of infiltrating T cells may even be a primary event in the
initiation of adipose tissue inflammation and development of IR
[1,2,3]. In this regard, there is considerable controversy, over the
precise subset of T cells that are important with some studies
suggesting a role for CD8
+ T [2] while others demonstrating a role
for CD4
+ TH1 cells [3]. Regulatory (Treg) cells may play a critical
role inmodulatinglevelsoftissue inflammationvia theirinteractions
with several components of the immune system. A well defined role
for these cells is in bridging interactions between responder/effector
T cells, and antigen presenting cells (APCs) via cytokines such as IL-
10 and TGFb and direct cytostatic interactions [5,6]. While Tregs
have been demonstrated to play an important role in tolerance and
auto-immunity in type I diabetes, several groups have recently
postulated a role for Tregs in experimental models of type II DM
and IR [3,7]. However the origin of these cells, their functional
determinants and whether or not a depletion of Tregs occurs in-vivo
in humans is unclear. In this paper we demonstrate a role for Tregs
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induced obesity (DIO), that a reduction in adipose Tregs is
associated with profound alterations in adipose tissue macrophages
(ATMs) and effector T cell populations.
Methods
Ethical Approval
This study and its procedures were approved by the
Committees on Use and Care of Animals and the Office of
Responsible Research Practices, Human Institutional Review
Board (IRB) of the Ohio State University under OSU protocol
#2008H0177. Human informed consent was obtained in writing
and a copy was inserted in the patients’ medical records.
Animals
Male Foxp3-GFP ‘‘knockin’’ mice (Foxp3gfp.KI) (N=10 mice/
diet group) wererandomized to a standard chow (SCD) or a highfat
diet (HFD – 60% energy from fat, Research Diets D12492) for 12
weeks. Before sacrifice, an intra-peritoneal glucose tolerance test
was performed. At sacrifice, serum was collected for insulin ELISA
(Crystal Chem Inc., IL USA). Homeostatic model assessment of
insulin resistance (HOMA-IR) and quantitative insulin sensitivity
check index (QUICKI) in mice were calculated as measures of beta
cell function and insulin sensitivity, respectively [8]. Mice were kept
on a 12/12 hr day/night schedule. Foxp3gfp.KI mice were a
generous gift of Mohamed Oukka and Vijay Kuchroo at Brigham
and Woman’s Hospital Harvard Medical School. These mice
express green fluorescent protein under control of a foxp3 promoter
without altering foxp3 expression on a C57BL/6 background
allowing in-vivo and in-vitro identification of Tregs (28).
Human Participants
The study recruited and obtained visceral adipose samples from
20 surgical patients [7 lean (BMI,30), 7 obese non-treated (OB;
BMI$30), and 6 obese treated (OBTD) patients]. Samples were
obtained from the greater omentum during endoscopic repair of
hernias from lean subjects and during the performance of bariatric
surgeries(OB/OBTD). The bariatricsurgeryperformed consisted of
laparoscopic banding in 10 subjects and gastric bypass in 7 subjects.
Mouse and Human Adipose Digestion
After excision, adipose was well rinsed in PBS, minced, and
digested with collagenase type II from Clostridium histolyticum
(1 mg/ml) at 37uC, 140 rpm as detailed previously (22). The
digesta was filtered through a 100 mm nylon cell strainer before
centrifugation (3006g, 10 minutes). The resulting pellet is the
stromal vascular fraction (SVF). Viable adipose tissue mononu-
clear cells were isolated from the SVF using Lympholyte M
(Cedarlane Laboratories Ltd, Birlington, NC) in mice and Ficoll-
Hypaque (GE Healthcare) in humans. Cells were washed and
resuspended in flow buffer before counting and staining for flow
cytometry. A portion was stored at 280uC in lysis buffer -
Absolutely RNA Kit (Agilent Technologies, Stratagene).
Splenic and mesenteric lymph node leukocyte isolation
Spleens and mesenteric lymph nodes [9] were isolated and
physically disrupted with the end of a syringe plunger, suspended
in complete DMEM growth media and then centrifuged at 3006g.
The resulting pellet was re-suspended in 16 red blood cell lysis
buffer (Biolegend), at room temperature with gentle shaking for 3
minutes followed by addition of 16PBS and centrifugation. Cells
were re-suspended in flow buffer (16PBS, 5% FBS).
Flow staining and cytometry
Cells were stained according to manufacturer’s instructions.
Briefly, approximately 1 mg of antibody was used per million cells
followed by incubation at 4uC for 15 minutes. Cells were
subsequently washed with flow buffer. GFP expressing cells were
run immediately while other samples were resuspended in 1%
neutral buffered formalin and analyzed by flow cytometry (BD
FACS LSR II
TM flow cytometer, Becton Dickinson, San Jose,
CA). Data was analyzed using BD FACS Diva software (Becton
Dickinson, San Jose,CA). All antibodies were purchased from
Biolegend, Miltenyi Biotec, or BDbioscience.
In-vitro Bone Marrow Derived Monocyte Culture and
Activation
Primary bone marrow derived monocytes (BMDM) were
cultured by flushing the femur and tibia with flow buffer, PBS
with 5% FBS. The cells were resuspended in BMDM growth
media (DMEM, 10% FBS plus L-cell conditioned media) in a CO2
incubator at 37uC for 5 days in a 150 mm suspension culture dish
(Corning Incorporated, Corning, NY). At day 5 BMDMs cells
were split into three groups: unstimulated control (UC), classically
activated, and alternatively activated cells. Classically activated
cells were primed with interferon gamma (R&D Systems IFNc
485-MI) 200 U/ml for 10 hrs followed by stimulation by the
addition of LPS (500 ng/ml) overnight. Alternatively activated
cells were treated with interleukin 4 (IL4) 20 U/ml (R&D Systems,
IL4 404-ML) overnight. The following day, the cells were washed
with PBS, BMDM growth media was provided, incubated for
24 hrs, and collected for use in conditioned media experiments.
CD4
+ cell isolation and Treg differentiation
Splenic CD4
+ cells from Foxp3gfp.KI mice were negatively
selected using a Miltenyi Biotec system. Briefly, non-CD4
+ splenic
cells are labeled by a cocktail of biotin-conjugated monoclonal
antibodies against mouse: CD8a, CD11b, CD45R, CD49b, and
Ter-119. Cells are secondarily labeled with colloidal super-
paramagnetic microbeads conjugated to a monoclonal anti-biotin
antibody and run through a Miltenyi column. The magnetically
labeled non-CD4
+ T cells are retained in the column, while sterile
CD4
+ T cells run through. The cells are passed through another
columntoincreasepurity.CD4
2cellsfromthecolumnflow-through
were irradiated at 25 Gy. CD4
+ T cells were grown in RPMI 1640
medium supplemented with 10 mM L-glutamine, 10 mM HEPES
buffer, 1 mM sodium pyruvate, 1% penicillin/streptomycin, and
10%fetalbovineserumsupplementedwith30%(v/v)ofconditioned
media from UC, CA, or AA groups (as described aboved) in the
presence of irradiated CD4
2 Tc e l l sa n da n t i - m o u s eC D 3 e antibody
at 2 mg/ml. Cells were cultured for 72 hours, collected, washed,
counted and stained with a-CD4 APC/Cy7 and analyzed by flow
cytometry for GFP expression as a marker of Treg differentiation.
Data Analysis
All data are expressed as mean 6 SEM unless otherwise
specified. Graphpad Prism software (Version 5) was used for
statistical analysis using the student’s t-test or one-way ANOVA
and Boneferroni’s post hoc test where appropriate. A P value of
,0.05 was considered statistically significant.
Results
Diet-induced Obesity and Macrophage Inflammation in
Mice
Foxp3gfp.KI mice developed insulin resistance after 12 weeks of
HFD feeding as measured by intraperitoneal glucose tolerance test
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(Table 1). Obese mice (46.260.9 g) weighed >70% more than
lean controls (27.661.3 g). Flow cytometric analysis of visceral
ATMs showed a > four-fold increase in CD11b
+ macrophages per
gram (Figure 1A–C). CD11b
+CD11c
+ macrophages were dramat-
ically increased with HFD. CD11b
+Ly6C
+ macrophages more
than doubled in HFD diet mice, a pro-inflammatory subset that
has been proposed to be recruited to visceral adipose tissue during
obesity (Figure 1A–C) [10,11,12,13,14,15]. We found an increase
(p=0.0543) in CD206
+ expressing ATMs in this model though
macrophage galactose N-acetyl-galactosamine specific lectin 1
(Mgl1) surface expression was not significantly different. To further
characerize the macrophage activation state, real time gene
expression analysis on the ATM/ATL fraction of the epididymal
adipose was performed. TNFa increased >6-fold in DIO,
indicating increased pro-inflammatory activation. Mgl1 and
arginase 1 (Arg1) gene expression were signficantly (p,0.005) lower
in the SVF of HFD mice as previously reported (Figure 1D) [16].
Lymphocytic Infiltration of Visceral Adipose in Obese
Mice
Total CD3
+, CD3
+CD4
+, and CD3
+CD8
+ populations dra-
matically increased in the epididymal adipose with DIO
(Figure 2A). It is important to note that CD8
+ T cells numbers
averaged >2-times that of CD4
+ cells/gram in DIO. Gene
expression of the TH2 marker GATA3 in the SVF was >2-fold
lower in the HFD (p,0.005) while expression of Tbx21 remained
comparable between the SCD and HFD groups (Figure 2B).
There was no signficant difference in gene expression of TGFb1,
IL6, IL4R, and IL12R between groups (data not shown).
Visceral Adipose Treg Deficiency in Obese Mice
Figure 3A depicts Treg content of epididymal adipose from
obese and lean animals. CD4
+CD25
+GFP
+ Tregs decreased from
9.5% in SCD to 2.3% in the HFD group (p,0.0001, HFD vs.
SCD). When normalized to epididymal adipose weight, Treg
numbers were comparable between groups. The degree of
Treg decrease was inversely correlated with the presence of
CD11c
+F4/80
+ cells (Figure 3B, R
2=0.54, p,0.01). In order to
determine if the depletion of Tregs in the adipose was a
consequence of a systemic decrease in Tregs, we analyzed splenic
content of Tregs. In contrast to the visceral adipose, there was a
significant increase in CD3
+GFP
+ and CD4
+GFP
+ cells in the
splenic response to HFD (Figure 3C, p,0.0008 & p,0.005
respectively vs. SCD) with a concominant decrease in total
splenic CD4
+ Tc e l l s( p ,0.005).
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Figure 1. Diet-induced Obesity and Macrophage Inflammation in Mice. Representative flow cytometric dot plots showing double positive
ATMs from Foxp3gfp.KI mouse epididymal adipose (N=10/group) (A & B). The monocyte macrophage marker (CD11b
+; y axis) is shown versus
inflammatory (CD11c, Ly6c) and putative anti-inflammatory (CD206, Mgl1) markers (x axis). Blue indicates CD11b positivity within the live singlet gate
(P1), red indicates P1 cells negative for CD11b. (C) There was a significant increase in inflammatory ATMs (CD11c
+; Ly6C
+) per gram of epididymal fat.
Putative anti-inflammatory markers were not significantly affected; however, CD206 expressing cells increased (p=0.0543). (D) There was a significant
(**; p,0.005) increase in TNFa gene expression in the stromal vascular fraction with HFD and a significant (***; p,0.0005) decrease in Mgl1 and Arg1
expression (N=6/group) as measured by real time PCR.
doi:10.1371/journal.pone.0016376.g001
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We hypothesized that the depletion of Tregs in fat may be
related to obesity-induced alterations in chemokine receptor
expression. Therefore, we analyzed surface expression of chemo-
kine homing receptors CXCR3 and CCR7 on T cells in spleen
and mesenteric lymph nodes (Figure 4A, B, D), two receptors
previously described to regulate the trafficking of Tregs [17,18,19].
The percentage of splenic CXCR3
+ Tregs nearly doubled in the
HFD group compared to the SCD group (Figure 4A, B;
p,0.0001). There was a non-significant increase in CXCR3
expression in mesentric lymph node-derived Tregs (Figure 4B).
Gene expression of the cognate ligand of the CXCR3 receptor,
CXCL10, in the adipose SVF was non-significantly increased in
the HFD group (Figure 4C). CCR7 expression in splenic Tregs
was markedly upregulated in response to HFD (Figure 4D;
p,0.0001).
Effects of HFD on T cell Activation
To better understand the activation status of effector and
regulatory T cells in the spleen, we analyzed surface expression of
CD44 and CD62L (L-selectin) in Foxp3gfp.KI mice (Figure 5A).
CD44 is upregulated on naı ¨ve T cells after T cell receptor
activation and has been shown to be required for activated T cell
extravasation into an inflammatory site [20,21]. DIO resulted in a
significant decrease in naı ¨ve CD4
+ T cells (CD44
2CD62L
+;
p,0.001) and central memory (CD44
+CD62L
+CCR7
+;p ,0.005)
cells, but an increase in activated CD4
+ cells (CD44
+CD62L
2;
Figure 5B; p,0.0005). When the expression of CD44 and CD62L
was examined in Tregs (CD4
+ GFP
+), we found that central
splenic memory Tregs were non-significantly decreased (Figure 5C;
p=0.051) and activated splenic Tregs were increased (Figure 5C;
p,0.0001). These results indicate that in response to DIO, there is
an increase of activated T effector cells and Tregs in the spleen,
suggesting that these cells are capable of mobilization to sites of
inflammation or to appropriate chemokine gradients in peripheral
tissue depots.
Treg Differentiation is Inhibited by an Inflammatory
Macrophage Milieu
Due to the paradoxical reduction of Tregs in visceral adipose in
the face of increased Tregs in the spleen and activation of these
cells in central reservoirs, we hypothesized that local activation
state of adipose macrophages may critically impact T reg
differentiation/maintenance. In order to test this hypothesis, we
differentiated bone marrow derived macrophages from
Foxp3gfp.KI mice and skewed their phenotype to a ‘‘pro-
inflammatory’’ state using classic signals (LPS+IFNc) or towards
an ‘‘anti-inflammatory’’ activation state (IL-4). Culture media
derived from these experiments were used in in-vitro Treg
differentiation assays.
Figure 6 depicts in-vitro differentiation of CD4
+CD3
+GFP
2 cells
from the spleen of Foxp3gfp.KI mice in response to condi-
tioned media derived from untreated, interleukin-4, or IFN-c
primed; LPS-stimulated macrophages. Approximately 12% of
CD3
+CD4
+GFP
2 cells grown in-vitro (Figure 6) in the presence of
conditioned media from untreated bone marrow-derived macro-
phages differentiate to GFP
+ Treg cells. In contrast, supplemen-
tation with conditioned media from IFNc+LPS activated macro-
phages suppressed differentiation levels, with GFP
+ cells reaching
5% (p,0.001 vs. unstimulated and alternatively activated groups).
In the absence of bone marrow-derived macrophage conditioned
media the differentiation rate was ,4% (data not shown). Dif-
ferentiation in the presence of conditioned media from IL-4-
stimulated macrophages did not increase Treg differentiation
beyond that of untreated media. This indicates that cytokines
produced by IFNc+LPS-stimulated macrophages prevent the
differentiation of CD4
+ T cell precursors to Tregs. It also suggests
that mediators secreted from an alternately differentiated macro-
phage do not have a detrimental effect of T cell precursor cell
differentiation to a Treg phenotype.
Human Biomorphic Data
Table 2 summarizes the biometric and metabolic data in
humans. Fasting glucose was highest in the obese-treated (OBTD)
group (13168.60 mg/dl, p,0.05 vs lean, obsese-nontreated), with
the obese non-treated (OB) group (98.766.23 mg/dl) exhibiting
Figure 2. Lymphocytic Infiltration of Visceral Adipose in Obese Mice. (A) Flow cytometric staining for the lymphocytic markers CD3, CD4,
and CD8 in Foxp3gfp.KI mice (N=10/group) demonstrated a significant lymphocyte infiltration of the epididymal fat pad with obesity and insulin
resistance. The CD8
+ T cell population was .2-fold that of CD4
+ per gram of adipose. (B) Gene expression of GATA3 and TBX21 in adipose-derived
lymphoid cells from mouse epididymal fat following Lympholyte M isolation.
doi:10.1371/journal.pone.0016376.g002
Table 1. Mouse metabolic parameters.
SCD (n=8) HFD (n=8) P-value
Weight (g) 27.661.28 46.260.885 0.0001
Oral GTT (AUC) 2335061276 4439062505 0.0001
Fasting Glucose (mg/dl) [G] 81.567.83 141.3367.74 0.0001
Fasting Glucose (mmol/L) [GO] 3.6460.250 7.8460.509 0.0001
Fasting Insulin (ng/ml) 0.47660.220 2.4860.378 0.0005
Fasting Insulin (mU/L) [IO] 14.565.18 61.569.38 0.0016
HOMA (GO*IO)/22.5 2.2360.76 21.063.11 0.0003
QUICKI 1/[log (IO)+log(G)] 0.36760.03 0.25660.005 0.0053
doi:10.1371/journal.pone.0016376.t001
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higher in the OB and OBTD groups (p,0.05 vs lean).
Hemoglobin A1c was non-significantly increased in the OBTD
group. HOMA-IR values were significantly higher in the OB and
OBTD groups (p,0.05 vs lean). C-reactive protein a sensitive
marker of subclinical inflammation [22] was equally raised in both
OB and OBTD groups, but did not reach signficance until both
groups were combined (Obese – All, p,0.05).
Human Obesity Results in Inflammatory Macrophage
Infiltration of Visceral Adipose
We evaluated total, pro- and anti-inflammatory macrophage
content of human greater omental fat, which is representative of
visceral adipose tissue depots using several widely-used markers.
Total macrophage content as measured by CD11b and the
scavenger receptor (CD36) per gram of tissue was not increased in
human obesity (Figure 7A, B). Interestingly, CD11c
+ cells showed
a trend toward an increase (Figure 7C). When the proportion of
total ATMs was analyzed for CD11c
+ expression, we found a
significant increase in the CD11c
+, pro-inflammatory macrophag-
es (Figure 7D, E). Surface expression of CD11b
+CD206
+ cells, a
putative surface marker of anti-inflammatory activation, on ATMs
was not affected in morbid obesity, though we observed a non-
significant (p=0.0543) increase in the Foxp3gfp.KI mouse model
[23]. Interestingly, CD11c
+CD206
+ cell content was significantly
increased (Figure 7F; p,0.05) per grams of omentum in the
OBTD group compared to lean controls; linear regression analysis
of CD11c
+CD206
+ cells/g tissue with HOMA-IR values in these
groups yielded a R
2 value of 0.59 (N=4/group).
Activation Increases in Human Visceral Adipose CD4
+ T
cell with Obesity
There was marked inter-sample variability amongst subjects
when expressed per gram of tissue; CD4
+ T cells, when expressed as
a percentage of total CD3
+, showed a non-significant decreased
with human obesity (Figure 8A). There was no clear evidence of
CD3
+ cell infiltration in obesity when normalized to grams of
adipose. CD25 is a traditional marker of T cell activation and is up-
regulated in naı ¨ve, non-regulatory CD4
+ T cells follow TCR
engagement [24]. Activated lymphocytes as measured by
Figure 3. Obesity Mediates Local Treg Deficiency in the Visceral Adipose of Obese Mice. Visceral Treg numbers were examined by flow
cytometry. (A) CD3
+ T cells were identified followed by quantification of CD25
+FoxP3
+ Tregs as shown in Q2 of representative dot plots. HFD mice
showed a 4-fold decrease in Tregs proportional to total CD3
+ T cells. When normalized to percent of SVF, CD3
+GFP
+CD25
+ decreased > 10-fold. (B)
There is an inverse relationship between the CD11c
+ inflammatory ATMs and Tregs (R
2=0.54). (C) HFD resulted in a significant increase in splenic
CD3
+GFP
+ and CD4
+GFP
+ Tregs, with a concomitant (p,0.005) decrease in total splenic CD4
+ T cells.
doi:10.1371/journal.pone.0016376.g003
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+CD4
+CD25
lo cells however were dramatically increased from
less than 10% in lean controls to greater than 20% in the OB
(p,0.05). The obese TD group showed a non-significant increase
similar to the OB group. CD3
+CD4
+CD25
hi cells were not readily
evident in human samples; thus we examined Foxp3 gene expression
in human omental samples, which showed a significantly (p=0.008)
lower level of expression compared to lean controls (Figure 8B).
Anti-Inflammatory T cell populations Decrease with
Human Obesity
We then analyzed gene expression of TH1 and TH2 markers in
human adipose to determine if there were differences in relative
expression of pro- and anti- inflammatory T cell subpopulations
markers. TH2 markers IL4R and GATA3 were lower in the obese
group compared to lean with no change in TH1 markers between
groups (Figure 8C). This indicates that in addition to a loss of Treg
populations there is a potential concomitant loss of other anti-
inflammatory T cell subsets. GATA3, is a key transcription factor
required for TH2 differentiation while the IL4 receptor is
expressed on TH2 CD4
+ T cells. In contrast TBX21 gene
expression (T-bet) a key regulator of TH1 differentiation was
unchanged as was observed in the mouse. These changes suggest a
skew towards a pro-inflammatory T cell phenotype within visceral
adipose tissue by virtue of reduced anti-inflammatory (Treg and
TH2) T cell populations. Together with a >30-fold higher IL-6
gene expression, these results are consistent with a pro-inflamma-
tory phenotype of visceral adipose tissue.
Discussion
In this paper we have demonstrated that visceral adipose depots
are associated with reduction in Treg numbers. This deficiency in
visceral adipose Tregs occurs in the context of increased splenic
Tregs with up-regulation of key homing receptors on these cells.
Treg differentiation was markedly impaired in response to culture
in the presence of conditioned media from activated macrophages.
Visceral adipose inflammation in obesity is a major pathophys-
iologic risk factor for the development of whole body IR. Aberrant
innate immune mechanisms have been postulated to be central to
‘‘metaflammation’’, a sine que non of IR in obesity and Type II
DM. Although Tregs have been investigated in animal models and
human subjects with autoimmune conditions and type 1 diabetes,
the role of Tregs in diet-induced experimental obesity has been
only recently recognized [3,7]. Moreover, the translatability of
these findings to human obesity has not been evaluated. Our study
provides new insights and extends prior observations that have
suggested a role for T cell subsets in the pathogenesis of IR [2,3,7].
Treg depletion in visceral adipose tissue correlated with markers of
innate immune activation and with the severity of IR at least in
rodents. The murine model used in this study is a relevant model
of diet-induced IR as evidenced by severe alterations in indices of
glucose homeostasis and development of characteristic visceral
adipose inflammation and infiltration by Ly6C
hi monocytes.
Circulating Ly6C
hi monocytes are known to be recruited to sites
of inflammation where they have been incriminated in genesis of
pro-inflammatory tissue macrophages [15]. Our results are in
keeping with recent data that have demonstrated an important
role for Macrophage galactose-type C lectin 1 (Mgl1) as an
important determinant of tissue infiltration by systemic monocytes
[25,26]. We found that CD11b
+ cells expressing Mgl1 on their
surfaces were not increased with DIO in our mouse model.
Interestingly, Mgl1 gene expression in the SVF was significantly
decreased in the HFD-mice. Although it is entirely likely that
strain differences may have contributed to these findings, it is also
Figure 4. Splenic Treg Homing Receptor Expression in Obesity. The expression of receptors and cognate ligands involved in Treg homing
were analyzed in the spleen and mesenteric lymph nodes (MLN, N=10/group). (A) Representative dot-plot and histogram of Treg CXCR3 expression
in SCD and HFD fed mice showing an increase in CXCR3 expressing Tregs in the spleen. (B) Analysis of splenic and mesenteric Tregs shows a non-
significant increase in CXCR3 expression in splenic Tregs with no difference in MLN Tregs. (C) CXCL10 gene expression, the cognate ligand of CXCR3
receptor, was measure in the SVF of Foxp3gfp.KI mice. (D) Surface expression of the CCR7 receptor in splenic Tregs was significantly increased
(p,0.0001) in the HFD group as measured by flow cytometry.
doi:10.1371/journal.pone.0016376.g004
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given time may reflect a balance between infiltrating and resident
macrophage populations.
The origin of adipose tissue Treg cells is currently not defined. It
is clear that uncommitted, peripheral naı ¨ve CD4
+ T lymphocytes
can differentiate into Tregs based on mode of stimulation, antigen
concentrationandcytokinemilieu[27].Thecurrentmodel forTreg
development suggests that ‘‘natural’’ Tregs generated in the thymus
home to peripheral tissues to maintain self-tolerance [28,29,30].
There is also some data to support generation of Tregs (inducible
Tregs) in the periphery during an active immune response [31,32],
though there are conflicting reports [33,34]. In humans, it has been
reported that CD25
+ Tregs are derived from a pool of peripheral
memory CD4
+ T cells in addition to the thymus [35]. Upon
observing a striking decrease in adipose Tregs in experimental
obesity, we asked if this was due to inhibition of local Treg
differentiation, alterations in homing, or a combination of both
mechanisms. Peripheral Treg numbers in mice were inversely
correlated with CD11c
+ macrophages suggesting that there may be
interactions between Tregs and macrophage/dendritic cells. Tregs
directly interact with macrophage/dendritic cells in tissue niches
where they inhibit T cell activation by blocking APC interactions
with CD4
+ effector T cells [3,5,6]. A loss of Tregs may potentiate
inflammation through influences on macrophage activation state,
which Tregs may influence via both cytokine-dependent (IL4, IL10,
IL13) and independent pathways [36].
A reduction in Treg numbers or function may lead to pro-
inflammatory skew in visceral adipose and may potentiate both
innate and adaptive immune inflammation. Thus a decrease in
Tregs may directly result in an increase in ‘‘activated’’ effector T cell
populations and issupported by ourstudies in miceand humansthat
show higher activated effector T cell populations. In keeping with
these data, Nishimura and colleagues demonstrate an improvement
in IR genetic depletion of CD8
+ cells while adoptive transfer of
CD8
+ T cells to CD8-deficient mice increased adipose inflammation
[2]. Winer and colleagues recently reported a role for adipose
infiltration by pro-inflammatory TH1 cells in the development of IR
[3]. They reported improved long-term glucose and insulin
homeostasis by CD3 antibody depletion in obese B6 mice with
concomitant restoration of epididymal Tregs; treatment was less
efficacious in an ob/ob model. However, adoptive transfer studies
using CD4
+Foxp3
2 T cells to HFD-fed Rag1-null mice showed
protection from weight gain and improvement in markers of glucose
metabolism which tempered the hypothesized role for Tregs.
Transfer of IL-10 null CD4
+ T cells showed similar protection,
indicating that Treg-mediated IL-10 production was not necessary
in mediating beneficial effects. In contrast, a newly identified group
of TGFb-dependent regulatory T cells which express surface
latency-associated peptide (LAP) have been shown by Ilan et al to
pivotally modulate visceral adipose inflammation [7]. Induction of
CD4
+LAP
+ Tregs by oral CD3 antibody as well as adoptive transfer
of CD4
+LAP
+ Tregs resulted in amelioration of markers of insulin
resistance in ob/ob mice. It is important to note that Winer also
showed that adoptive transfer of CD4
+ STAT6-null T cells to HFD-
fed Rag1-null mice did not result in significant improvement in
glucose metabolism as did WT CD4
+ transferred cells. This was
attributed to a reduced number of CD4
+GATA3
+ TH2 T cells
generated from the STAT6-null adoptive transfer. Our data show
that murine obesity lead to splenic CD4
+ T cell activation.
CD44 expression is required for the development of memory T
cells [37] and is increased upon TH1 cell activation and clonal
expansion. Importantly, CD44 expression also mediates T cell
migration and extravasation into tissues by acting as an adhesion
molecule recognizing extracellular matrix molecules such as
hyaluronin and protein ligands such as osteopontin that are
produced during inflammation by TH1 cells [38]. At least 20
Figure 6. Treg Differentiation is Inhibited by an Inflammatory Macrophage Milieu. Splenic CD4
+ cells from Foxp3gfp.KI were negatively
selected in the presence of irradiated CD4
2 T cells, anti-mouse CD3e antibody, and conditioned media from untreated, IL4-, or IFNc+LPS-
differentiated bone marrow-derived macrophages. Cells were cultured for 72 hours, collected, stained, and analyzed by flow cytometry for CD4 and
GFP expression as a marker of Treg differentiation. The IFNc+LPS-CM group showed a significant (**, p,0.005) decrease in in vitro Treg differentiation
when compared to the UT-CM group.
doi:10.1371/journal.pone.0016376.g006
Figure 5. Diet-induced Obesity in Mice Activates Splenic T Helper and Tregs. The effect of DIO on CD4
+ (A–D) and Tregs (E–G) sub-
populations. (A) Representative dot-plot demonstrating isolation of CD4
+ cells and analysis of expression of CD44, CCR7 (central memory cells) and
CD62L (activation marker). (B) DIO resulted in a decrease in central memory and naı ¨ve T helper cells (p,0.005; p,0.001, respectively) and an increase
in activated cells (p,0.0005) (C). Representative dot-plots of CD4
+, GFP
+ Tregs, showing CD44, CCR7 and CD62L expression. Splenic central memory
Tregs (CD44
+CD62L
+CCR7
+) showed a decrease (p=0.051) while activated splenic Treg (CD44
+CD62L
2) were increased (p,0.0001).
doi:10.1371/journal.pone.0016376.g005
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minimum of six CD44 protein products have been identified [40]
though a standard 85–95-kDa form (CD44s) is the primary form
expressed on lymphocytes [41,42]. During T cell stimulation,
expression of CD44 variants (v3, v6, v9) may be necessary for
functional changes post-stimulation [43,44]. It should be noted
that the antibody we utilized has been reported to be specific to all
CD44 isoforms. The role of CD44 splice variants in in-vivo T cell
subpopulations is mostly likely of great immunological relevance.
Thus, understanding in-vivo CD44 splice variant expression on T
cell subsets during inflammatory processes such as obesity-
mediated insulin resistance is an important area for further study.
Decreased GATA3 expression in the SVF of obese mice and
humans indicates a decrease in TH2 cells with the development of
insulin resistance. The decrease inIL4R expressionin obese humans
also supports this hypothesis. Our data taken in the context of these
reports indicates that there is a population shift from anti-
inflammatory T cell subsets (Tregs, TH2 cells) to inflammatory T
Figure 7. Human Obesity Results in Inflammatory Macrophage Infiltration of the Greater Omentum. ATMs were analyzed in the stromal
vascular fraction of omental tissue from lean, obese and obese subjects who were being treated for insulin resistance (Obese TD). (A–B) depicts
analysis of CD11b
+ and CD36
+ expressing ATMs/g of adipose tissue demonstrating no difference between groups. (C) CD11c
+ cells per gram of
adipose were non-significantly increase in both obese and obese TD groups. (D) CD11c
+ cells expressed as percent of total CD11b
+ and (E) as percent
of CD36
+ ATM demonstrating an increase in both obese and obese TD groups (p,0.05, vs lean). (F) CD11c
+CD206
+ ATMs were significantly increased
(p,0.05) in the obese TD group, which was also characterized by the highest indices of insulin resistance (see table 2). (G) Linear regression plot of
CD11c
+CD206
+ content in lean and obese TD individuals against HOMA-IR values (N=4/group; R
2=0.59).
doi:10.1371/journal.pone.0016376.g007
Table 2. Human metabolic parameters.
Lean (n=5) Ob (n=7) ObTd (n=4) Obese – All (n=11)
Weight (lb) 169611.1 264614.9* 317617.4*{,2 9 0 619.2*
BMI 27.160.524 45.662.51* 49.461.97* 48.862.79*
Fasting Glucose (mg/dL) 90.469.08 98.766.23 13168.60*,{ 11069.44*
Fasting Insulin (mU/L) 3.3260.504 9.1060.346* 13.760.478* 10.860.524*
Hem A1c (%) 5.5660.114 5.6160.148 7.2061.00 6.2960.649
QUICKI 0.42560.0203 0.35060.0163* 0.31760.0150* 0.33860.0165*
HOMA 0.76060.287 2.2160.450* 4.5061.05* 3.0460.824*
Total Cholesterol (mg/dL) 17168.54 170610.7 146610.4 162611.2
Triglycerides (mg/dL) 123628.7 115621.8 163613.6 132620.9
LDL (mg/dL) 10269.87 113610.4 85.864.29 103610.1
HDL(mg/dL) 55.063.92 34.163.30 27.865.75 31.864.27
CRP (mg/dL) 2.3660.734 9.2662.07 8.9764.07 9.1562.74*
Fasting bloods were collected at time of surgery and sent to OSU clinical laboratories for analysis. Patient data were stratified to three groups (lean; OB, obese non-
treated; OBTD, obese treated). Obese-ALL refers to the values and statistical analysis if patients were stratified by a BMI $30 alone, ignoring pharmaceutical treatments
(*, p,0.05, group vs lean; {,p ,0.05, OBTD vs OB).
doi:10.1371/journal.pone.0016376.t002
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leading to the development of IR and Type II DM.
Conditioned media from IFNc+LPS-activated macrophages
reduced spontaneousTreg differentiation ina murineCD4
+CD25
2
T cell proliferation assay, while media from IL4-activated BMDMs
insignificantly increased differentiation beyond that of untreated
control media. This suggests that cytokines produced by infiltrating
macrophages may play a role in suppressing local adipose Treg
differentiation. To address the role of homing of peripheral Tregs to
the adipose we examined splenic CXCR3 expression, a critical
receptor required for T cell homing and found an increase (rather
than decrease) in expression of this receptor in central lymphoid
tissues. The lymphoid homing receptor, CCR7, was also increased
in splenic Tregs in obesity. Taken together with the results
suggesting a lack of effect of obesity in reducing central Treg
numbers and homing receptors, we hypothesize that reduced Treg
numbers in obesity may represent a functional consequence of
macrophage derived inflammatory signals.
The studies in humans demonstrated a relatively more modest
effect on inflammation based on absolute numbers of macrophages,
though proportional increases in inflammatory macrophages were
evident. We observed high within-group variability with respect to
CD3
+ cells/g and CD4
+ cells/g that did not correlate with BMI.
However, ‘‘activated’’ lymphocytes were consistently and statistically
higher in the obese patients when compared to the lean human
controls. There was a skew away from a TH2 phenotype towards a
TH1 phenotype as evidenced by a marked decrease in GATA3 and
IL4R with constant levels of TBX21 expression as described
previously [45]. The expression of foxp3 in human omentum was
diminished in keeping with results in our murine experiments.
However in our study CD11c
+CD206
+ cells in humans were also
increased, similar to the results reported in the mouse model.
CD11c
+CD206
+ cells have recently been shown to play an
important facilitatory role in adipose inflammation and insulin
resistance but are unique as they also demonstrate features of
alternatively activated macrophages such as high levels of IL10, high
mitochondrial copy number, and scavenger receptor expression
[23]. Thus, the binary M1/M2 paradigm in mouse ATMs may not
be entirely applicable to humans. In keeping with these findings, the
scavenger receptor CD36 was markedly increased in human obesity.
Temporal analysis of Tregs levels in the context of visceral
immune and adipcyte phenotypes during DIO may have added
valuable insights. The scope of the study was additionally limited
as we did not perform interventions to modulate Tregs in visceral
adipose tissue. Nevertheless, the use of human visceral adipose
tissue from a patient population with morbid obesity (BMI.35)
and an effective murine model to study Tregs in DIO allowed us
to add clear data concerning the status of T cell and macrophage
inflammation in the adipose. Further study is needed to
characterize the direct and indirect interactions of dendritic,
macrophage, and T cell subpopulations and the roles these
interactions play in the etiology of DIO and IR. Better
understanding may facilitate the development of a targeted
pharmaceutical intervention that disrupts or enhances key
interactions which modulate adipose inflammation resulting in
improved systemic insulin resistance and metabolic syndrome.
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statistical significance (p,0.0001) at all collection points when
compared to SCD mice at corresponding intervals.
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